Evidence map›Paper›PMID 37513319›Full record

ArticleMolecules (Basel, Switzerland)2023

Golden Buckwheat Extract-Loaded Injectable Hydrogel for Efficient Postsurgical Prevention of Local Tumor Recurrence Caused by Residual Tumor Cells.

Li Xie, Rong Liu, Dan Wang, Qingqing Pan, Shujie Yang, Huilun Li, Xinmu Zhang, Meng Jin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Molecular mechanisms underlyingFrontiers in pharmacology · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Li XieSchool of Preclinical Medicine, Chengdu University, Chengdu 610106, China.
Rong LiuSchool of Preclinical Medicine, Chengdu University, Chengdu 610106, China.
Dan WangDepartment of Pharmacy, Sichuan Nursing Vocational College, Chengdu 610100, China.
Qingqing PanSchool of Preclinical Medicine, Chengdu University, Chengdu 610106, China.
Shujie YangDepartment of Pharmacy, Chengdu University, Chengdu 610059, China.
Huilun LiClinical Medical College, Chengdu University, Chengdu 610106, China.
Xinmu ZhangDepartment of Pharmacy, Chengdu University, Chengdu 610059, China.
Meng JinSchool of Preclinical Medicine, Chengdu University, Chengdu 610106, China.
Chengdu University · CNChengdu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To prevent local tumor recurrence caused by possible residual cancer cells after surgery, avoid toxicity of systemic chemotherapy and protect the fragile immune system of postsurgical patients, an increasing amount of attention has been paid to local anti-cancer drug delivery systems. In this paper, golden buckwheat was first applied to prevent post-operative tumor recurrence, which is a Chinese herb and possesses anti-tumor activity. Golden buckwheat extract-loaded gellan gum injectable hydrogels were fabricated via Ca

Indexed as

Antineoplastic AgentsFagopyrumAnimalsCell Line, TumorHumansHydrogelsMiceNeoplasm Recurrence, LocalNeoplasm, ResidualNIH 3T3 CellsSpectroscopy, Fourier Transform InfraredAntineoplastic AgentsHydrogelsgolden buckwheat extractinjectable hydrogellocalized chemotherapy

Identifiers

PMID37513319
PMCPMC10383787
OpenAlexW4384557495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.